公司资料
BioLife Solutions 股价、新闻与催化剂
- 股票代码:
- BLFS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
35.45 USD (+1.08%)
收盘价
最后更新: 2026年8月17日
1.34B USD
市值
股价为何变动
As of Aug 17, 2026, BLFS closed up 1.08% at $35.45. No new same-company headline was identified in the current news window.
公司概览
业务概览
BioLife Solutions is a life-sciences tools company focused on biopreservation, storage, and cryogenic logistics for cell and gene therapy workflows. Its products support the manufacturing and handling side of advanced therapies.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, BioLife sits in biotech infrastructure.
商业模式特征
Revenue comes from consumables, storage systems, and workflow tools used by advanced-therapy developers.
生物医药行业定位
BioLife is an enabling platform name whose value tracks cell and gene therapy infrastructure spending.
未来催化剂
- BioLife Solutions's catalysts are cryopreservation demand and cell-therapy workflow growth, both of which depend on whether the broader cell-therapy market keeps recovering. The company can improve quickly if cell therapy activity really normalizes.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。